Roth Capital analyst Matt Koranda raised the firm’s price target on Gentherm (THRM) to $42 from $38 and keeps a Buy rating on the shares. Gentherm delivered a solid Q2, with better-than-feared sales, but largely in line with global automotive production, the analyst tells investors in a research note. Roth notes good new program award performance, and an adjacent market strategy that looks more promising as management unveils additional details.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THRM:
